HomeANIP • NASDAQ
add
ANI Pharmaceuticals Inc Common Stock
Previous close
$84.83
Day range
$83.03 - $86.59
Year range
$54.10 - $99.50
Market cap
1.93B USD
Avg Volume
488.22K
P/E ratio
52.89
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 227.81M | 53.58% |
Operating expense | 111.19M | 16.86% |
Net income | 26.62M | 210.14% |
Net profit margin | 11.68 | 171.70% |
Earnings per share | 2.04 | 52.24% |
EBITDA | 45.86M | 683.46% |
Effective tax rate | 21.25% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 271.47M | 77.11% |
Total assets | 1.41B | 9.38% |
Total liabilities | 902.34M | 5.34% |
Total equity | 505.82M | — |
Shares outstanding | 20.90M | — |
Price to book | 3.51 | — |
Return on assets | 4.22% | — |
Return on capital | 5.22% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | 26.62M | 210.14% |
Cash from operations | 44.06M | 253.17% |
Cash from investing | -6.16M | 98.45% |
Cash from financing | 6.34M | -97.82% |
Net change in cash | 44.81M | 147.13% |
Free cash flow | 19.38M | 327.68% |
About
Founded
2001
Headquarters
Website
Employees
897
